Sort by
Refine Your Search
-
following treatment. NEWDAY-ABC is a hybrid intervention-implementation trial that will be carried out at four sites across Yorkshire and Greater Manchester. The parallel process evaluation will assess
-
workshops and producing accessible toolkit resources, with a proof-of-concept focused on diabetes prevention for women of South Asian and Black African heritage. In parallel, the post holder will work
-
bioinformatics. The role will be responsible for developing and characterising human dorsal root ganglia cultures to benchmark the newly developed iPSC derived organoid model systems. This will include processing
-
of multiple medicines across cellular mechanisms in parallel, ensuring accelerated assessment of existing and new therapies. Improving our understanding of the cellular basis of disease will help bridge the gap
-
bioinformatics. The role will be responsible for developing and characterising human dorsal root ganglia cultures to benchmark the newly developed iPSC derived organoid model systems. This will include processing
-
parallel, the Institute is developing state-of-the-art methods that integrate living tissues with synthetic scaffolds to model and repair organs. These efforts converge across three interrelated programmes